Hematology TimesOmacetaxine mepesuccinate gets full FDA approvalFebruary 16, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesAffluence seems to affect CML survival in the UKFebruary 5, 2014Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesPonatinib back on the marketJanuary 19, 2014Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesOut-of-pocket costs hinder adherence to imatinibJanuary 8, 2014Leukemia, Myelodysplasia, TransplantationPharmacyCML
The Journal of Community and Supportive OncologyOmacetaxine for chronic or accelerated phase CML in patients with resistance or intolerance to TKIsSeptember 3, 2013Leukemia, Myelodysplasia, TransplantationPractice ManagementCMLBusiness of Medicine
Hematology TimesFDA approves 3rd-generation TKI for CMLSeptember 6, 2012Leukemia, Myelodysplasia, TransplantationCML
